tradingkey.logo
tradingkey.logo
Search

Annovis Bio Inc

ANVS
Add to Watchlist
1.660USD
-0.095-5.43%
Close 07-24 16:00ETQuotes delayed by 15 min
33.51MMarket Cap
LossP/E TTM

ANVS Financials

See Annovis Bio Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Annovis Bio Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.63/-0.39
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-1.40
30.45%
Analyst Rating
BUY
2026/07/25
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-99.03%-0.63
4.65%-0.38
62.12%-0.37
28.10%-0.32
-216.32%-0.32
81.99%-0.40
40.35%-0.97
58.33%-0.44
91.55%-0.10
-490.41%-2.24
---1.63
---1.07
---1.19
---0.38
---2.16
----
----
----
----
----
Net Profit
-217.97%-17.61M
-67.69%-9.83M
42.53%-7.26M
-23.90%-6.22M
-418.96%-5.54M
73.60%-5.86M
14.12%-12.64M
47.36%-5.02M
89.04%-1.07M
-617.77%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
47.68%-3.09M
-125.82%-6.43M
-135.14%-5.94M
-63.58%-5.23M
-246.98%-5.91M
-183.02%-2.85M
-9.31%-2.52M
Debt to assets ratio
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
----
Operating profit
-185.10%-17.91M
-44.12%-9.71M
-69.45%-7.43M
19.21%-6.27M
19.55%-6.28M
35.50%-6.73M
70.48%-4.39M
20.46%-7.76M
21.66%-7.81M
-229.52%-10.44M
-129.20%-14.86M
-63.41%-9.76M
-89.77%-9.97M
46.47%-3.17M
-127.24%-6.48M
-135.68%-5.97M
-62.69%-5.25M
-210.01%-5.92M
-77.94%-2.85M
0.37%-2.53M
Net Profit
-217.97%-17.61M
-67.69%-9.83M
42.53%-7.26M
-23.90%-6.22M
-418.96%-5.54M
73.60%-5.86M
14.12%-12.64M
47.36%-5.02M
89.04%-1.07M
-617.77%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
47.68%-3.09M
-125.82%-6.43M
-135.14%-5.94M
-63.58%-5.23M
-246.98%-5.91M
-183.02%-2.85M
-9.31%-2.52M
Current assets
-39.25%16.24M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
-69.42%7.81M
-71.66%10.21M
-68.53%10.22M
-37.53%22.82M
-40.99%25.55M
-21.69%36.02M
-31.82%32.49M
-26.21%36.53M
625.85%43.30M
466.57%46.00M
406.81%47.65M
385.20%49.50M
Total current liabilities
410.73%12.79M
-6.33%3.64M
-30.75%3.73M
-30.86%2.81M
-48.58%2.50M
-9.30%3.88M
51.24%5.39M
95.64%4.06M
-10.00%4.87M
-44.42%4.28M
41.10%3.56M
59.60%2.07M
330.69%5.41M
411.02%7.70M
125.46%2.53M
46.98%1.30M
-21.31%1.26M
160.47%1.51M
298.71%1.12M
25.77%884.08K
Total assets
-39.25%16.24M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
-69.42%7.81M
-71.66%10.21M
-68.53%10.22M
-37.53%22.82M
-40.99%25.55M
-21.69%36.02M
-31.82%32.49M
-26.21%36.53M
625.85%43.30M
466.57%46.00M
406.81%47.65M
385.20%49.50M
Total liabilities
388.85%13.12M
-8.39%4.23M
-44.74%4.03M
-54.04%3.12M
-75.97%2.68M
-74.29%4.62M
104.71%7.30M
227.76%6.80M
106.37%11.17M
133.28%17.96M
41.10%3.56M
59.60%2.07M
330.69%5.41M
411.02%7.70M
125.46%2.53M
46.98%1.30M
-21.31%1.26M
160.47%1.51M
298.71%1.12M
25.77%884.08K
Total equity
-87.00%3.13M
81.05%16.85M
86.25%13.16M
1146.93%18.33M
817.16%24.05M
220.09%9.31M
6.09%7.06M
-108.44%-1.75M
-116.66%-3.35M
-127.37%-7.75M
-77.78%6.66M
-41.12%20.74M
-52.10%20.14M
-36.34%28.32M
-35.61%29.96M
-27.54%35.23M
862.40%42.04M
490.04%44.49M
410.14%46.53M
411.80%48.61M
Net operating income
-11.27%-9.01M
-7.74%-8.93M
-8.94%-3.49M
-51.28%-5.11M
-15.16%-8.10M
11.53%-8.29M
65.83%-3.20M
64.86%-3.38M
39.51%-7.03M
-159.46%-9.36M
-135.00%-9.37M
-43.49%-9.61M
-284.75%-11.63M
-104.00%-3.61M
-128.70%-3.99M
-112.89%-6.69M
-22.10%-3.02M
-131.00%-1.77M
-88.95%-1.74M
-139.71%-3.14M
Net financing
-81.31%3.70M
112.45%13.17M
-86.12%1.64M
-100.00%0.00
348.10%19.78M
-29.25%6.20M
--11.84M
-50.58%4.24M
59675.25%4.42M
--8.76M
--0.00
--8.57M
60.11%7.39K
--0.00
100.00%0.00
-100.00%0.00
52.90%4.61K
--0.00
---25.46K
103133.67%46.77M

FAQs

What are the current assets of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its current assets were 21.08M, with a year-on-year change of 51.39.

What are the total assets of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its total assets of Annovis Bio Inc were 21.08M, with a year-on-year change of 51.39.

What are the total liabilities of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its total liabilities of Annovis Bio Inc were 4.23M, with a year-on-year change of -8.39.

What is the total equity of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its total equity of Annovis Bio Inc was 16.85M, with a year-on-year change of 81.05.

What is the net operating income of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its net operating income of Annovis Bio Inc was -29.70M, with a year-on-year change of -11.24.

What is the net financing of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its net financing of Annovis Bio Inc was 34.60M, with a year-on-year change of 29.63.

What is the Earnings Per Share (EPS) of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.40, with a year-on-year change of 30.45.

What is the net income of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its net income was -28.85M, with a year-on-year change of -17.34.

What is the Return on Equity (ROE) of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its Return on Equity (ROE) was -220.61, with a year-on-year change of 93.02.

What is the Return on Assets (ROA) of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its Return on Assets (ROA) was -164.85, with a year-on-year change of 19.11.

What is the operating profit of Annovis Bio Inc?

According to Annovis Bio Inc's FY2025 earnings report, its operating profit was -29.70M, with a year-on-year change of -11.24.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.